Smiths Medical Gets US Government Order For Safety Hypodermic Syringes
Smiths Medical has been selected for a $10m contract from the US Department of Health and Human Services (HHS) for safety hypodermic syringes. The award is part of
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.
Zogenix and Desitin Pharmaceuticals (Desitin) have reported that Desitin has filed for European regulatory approval of Sumavel DosePro (sumatriptan injection) needle-free delivery system. Reportedly, the announcement follows successful
AstraZeneca has withdrawn the regulatory submissions for the use of Zactima (vandetanib) 100mg in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC), from FDA